Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 4Withdrawn 1Unknown 1Recruiting 1Not yet recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Neuroblastoma 2Neoplasm Metastasis 2Leukemia, Myeloid, Acute 2Hodgkin Disease 2Stomach Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Recurrence 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Oropharyngeal Neoplasms 1Myelodysplastic Syndromes 1Multiple Myeloma 1Leukemia, Myeloid 1Head and Neck Neoplasms 1Carcinoma, Renal Cell 1Carcinoma, Hepatocellular 1

Interventions

pembrolizumab 4Cisplatin 4Blood Specimen Collection 4Cyclophosphamide 3130-nm albumin-bound paclitaxel 3fludarabine 2Tissue Banks 2Surgical Procedures, Operative 2Nivolumab 2Docetaxel 2tislelizumab 1fludarabine phosphate 1cemiplimab 1Therapeutics 1Surgical Flaps 1Standard of Care 1Sodium Chloride 1Radiotherapy, Intensity-Modulated 1Radiotherapy 1Radiation Dose Hypofractionation 1Neoadjuvant Therapy 1Methotrexate 1Magnetic Resonance Spectroscopy 1Magnetic Resonance Imaging 1Low-Level Light Therapy 1Ketamine 1Immune Checkpoint Inhibitors 1Gastroscopy 1Etoposide 1Electric Stimulation 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Not yet recruiting × Head and Neck Neoplasms × fludarabine phosphate × Clear all
NCT05582590 2024-01-16

Autologous T Cells Targeting HPV16 HPV18 & Survivin in Patients With R/R HPV-related Oropharyngeal Cancers

NexImmune Inc.

Phase 1 Not yet recruiting
36 enrolled
Head & Neck

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms, Neoplasm Metastasis, Oropharyngeal Neoplasms, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon âš¡